State regulators, Type One Energy, and the Tennessee Valley Authority (TVA) announced today the initial submission of a “byproduct material license” application in preparation for Tennessee’s first ...
Credit: Shutterstock. The sNDA is supported by data from the phase 3 DINAMO trial, which include patients 10 to less than 18 years of age with type 2 diabetes who are currently receiving metformin, ...
A Prescription Drug User Fee Act target date of December 20, 2024 has been set for the resubmitted application. The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug ...
Fractyl Health announced a first-in-human trial for RJVA-001, targeting T2D and obesity, pending regulatory approval by 2026. Fractyl Health, Inc. has announced the submission of the first module of ...
Tissue motions were detected on each frame of the B-mode images and motions in CEUS sequence were corrected accordingly. MBs were localized by peak detection after thresholding on both original CEUS ...
Entry of most application information directly into a web form: It is highly recommended that you collect this information in a document that you can easily copy from and paste into the web form. We ...
The application itself is subject to the application deadline (listed above). Additional required materials (items such as recommendations, transcripts, etc.) that are not automatically submitted with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results